156 related articles for article (PubMed ID: 3410347)
1. Application of an ATP-bioluminescence assay in human tumor chemosensitivity testing.
Sevin BU; Peng ZL; Perras JP; Ganjei P; Penalver M; Averette HE
Gynecol Oncol; 1988 Sep; 31(1):191-204. PubMed ID: 3410347
[TBL] [Abstract][Full Text] [Related]
2. [Application of a micromethod in ovarian cancer chemosensitivity testing in vitro].
Liu S; Qian X; Peng Z; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):298-9, 312. PubMed ID: 12947719
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
[TBL] [Abstract][Full Text] [Related]
4. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
Shi W; Gu M; Liang L
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
[TBL] [Abstract][Full Text] [Related]
5. Luminescence applications for chemotherapeutic drug development.
Andreotti PE; Caceres G; Zamkina R; Dauphinée M
Recent Results Cancer Res; 2003; 161():3-12. PubMed ID: 12528794
[TBL] [Abstract][Full Text] [Related]
6. [Value of the adenosine triphosphate chemosensitivity assay for pre-therapeutic determination of the chemosensitivity of breast cancer cells in cell culture].
Köchli OR; Sevin BU; Schär G; Haller U
Geburtshilfe Frauenheilkd; 1995 Jan; 55(1):7-16. PubMed ID: 7705600
[TBL] [Abstract][Full Text] [Related]
7. [-Chemosensitivity testing in gynecologic oncology. Experiences with an ATP bioluminescence assay-].
Kurbacher CM; Mallmann P; Kurbacher JA; Hübner H; Krebs D
Geburtshilfe Frauenheilkd; 1996 Feb; 56(2):70-8. PubMed ID: 8647362
[TBL] [Abstract][Full Text] [Related]
8. [An evaluation of adenosine triphosphate bioluminescence assay for tumor in vitro chemosensitivity testing].
Liu S; Peng Z; Lou J; Wang H; Tang Q; He B
Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):330-3. PubMed ID: 12545824
[TBL] [Abstract][Full Text] [Related]
9. [A new chemosensitivity test for cancer cells by measuring intracellular ATP content].
Nogaki M; Ichihashi H
Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1950-6. PubMed ID: 3231205
[TBL] [Abstract][Full Text] [Related]
10. Application of the adenosine triphosphate-cell viability assay in human breast cancer chemosensitivity testing: a report on the first results.
Koechli OR; Avner BP; Sevin BU; Avner B; Perras JP; Robinson DS; Averette HE
J Surg Oncol; 1993 Oct; 54(2):119-25. PubMed ID: 8412158
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the ATP chemosensitivity assay in epithelial ovarian cancer.
O'Meara AT; Sevin BU
Gynecol Oncol; 2001 Nov; 83(2):334-42. PubMed ID: 11606094
[TBL] [Abstract][Full Text] [Related]
12. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
13. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
[TBL] [Abstract][Full Text] [Related]
14. The use of ATP bioluminescence assays in selecting a drug screen panel for chemosensitivity testing of uterine cancer cell lines.
Nguyen HN; Sevin BU; Averette HE; Perras J; Donato D; Penalver M
Gynecol Oncol; 1992 May; 45(2):185-91. PubMed ID: 1592285
[TBL] [Abstract][Full Text] [Related]
15. [Predicting clinical chemo-sensitivity of primary ovarian cancer using adenosine triphosphate-tumor chemosensitivity assay combined with detection of drug resistance genes].
Zhao D; Zhang W; Li XG; Wang XB; Zhang LF; Li M; Li YF; Tian HM; Song PP; Liu J; Chang QY; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2011 Mar; 46(3):193-8. PubMed ID: 21575453
[TBL] [Abstract][Full Text] [Related]
16. [In vitro chemosensitivity testing evaluated by intracellular ATP level: ATP assay].
Maehara Y; Anai H; Masuda H; Miyamoto K; Fukuchi K; Tamada R; Sugimachi K
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2342-5. PubMed ID: 3729490
[TBL] [Abstract][Full Text] [Related]
17. Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro.
Kangas L; Grönroos M; Nieminen AL
Med Biol; 1984; 62(6):338-43. PubMed ID: 6543460
[TBL] [Abstract][Full Text] [Related]
18. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
19. [Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay].
Untch M; Sevin BU; Untch A; Konecny G; Nestle-Krämling C; Korell M; Hepp H
Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():311-3. PubMed ID: 7906979
[No Abstract] [Full Text] [Related]
20. Tumor heterogeneity and in vitro chemosensitivity testing in ovarian cancer.
Sevin BU; Perras JP
Am J Obstet Gynecol; 1997 Apr; 176(4):759-66; discussion 766-8. PubMed ID: 9125599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]